- Expert round table «Vaccination against Pneumococcal Infection of Children at Risk», Kyiv, (25.01.2020) with the results of the final discussion on 29.04.2020. Resolution
Expert round table «Vaccination against Pneumococcal Infection of Children at Risk», Kyiv, (25.01.2020) with the results of the final discussion on 29.04.2020. Resolution
REFERENCES
1. Bonten MJ, Huijts SM, Bolkenbaas M et al. (2015). Polysaccharide conjugate vaccine against pneumococcal pneumonia in adultsexternal icon. N Engl J Med. 372(12): 1114—25. https://doi.org/10.1056/NEJMoa1408544; PMid:25785969
2. Chernysheva LI, Gilfanova AM, Bondarenko AV et al. (2014). Effect of early social activity in S. pneumoniae nasopharyngeal carriage and distribution of pneumococcus serotypes in children of the first five years of life. Sovremennaya pediatriya. 2(58): 56—63. doi 10.15574/SP.2014.58.58
3. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990—2016. (2018, Nov). A systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 18(11): 1191—1210.
4. Ewald H, Briel M at al. (2016, Mar). The Clinical Effectiveness of Pneumococcal Conjugate Vaccines. A Systematic Review and Meta-analysis of Randomized Controlled Trials. Dtsch Arztebl Int. 113(9): 139—146. https://doi.org/10.3238/arztebl.2016.0139; PMid:26987462 PMCid:PMC4802351
5. Johnson HL et al. (2010). Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 7: pii:e1000348. https://doi.org/10.1371/journal.pmed.1000348; PMid:20957191 PMCid:PMC2950132
6. Pilishvili T, Bennett NM. (2015). Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccinesexternal icon. Vaccine. 33(4): D60-5. https://doi.org/10.1016/j.vaccine.2015.05.102; PMid:26116257
7. Pro udoskonalennia provedennia profilaktychnykh shcheplen v Ukraini. Nakaz MOZ Ukrainy vid 16 veresnia 2011 roku No. 595 (u redaktsii nakazu MOZ Ukrainy vid 11 serpnia 2014 roku No. 551). https://ips.ligazakon.net/document/view/re19898?an=1.
8. Rukovodstvo po planovoy immunizatsii vo vremya pandemii COVID-19 v Evropeyskom regione VOZ. http://www.euro.who.int/__data/assets/pdf_file/0005/433814/Guidance-routine-immunization-services-COVID-19-pandemic-rus.pdf?ua=1
9. Torres A, Blasi F, Dartois N, Akova M. (2015). Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 70(10): 984—989. https://doi.org/10.1136/thoraxjnl-2015-206780; PMid:26219979 PMCid:PMC4602259.
10. Wahl B et al. (2018). Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000—15. Lancet Global Health. 6(7): e744—57. https://doi.org/10.1016/S2214-109X(18)30247-X
11. WHO position paper — February 2019. Pneumococcal conjugate vaccines in infants and children under 5 years of age. Weekly epidemiological record. 8; 94: 85—104.